Form 4: Cargo Therapeutics Officer Sells Shares to Cover Tax Obligations

Anup Radhakrishnan, Interim CEO, CFO, and COO of Cargo Therapeutics, sold 1,629 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 3, 2025, Anup Radhakrishnan, Interim Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer of Cargo Therapeutics, Inc. (CRGX), sold 1,629 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $4.0037, with individual trades ranging from $4.00 to $4.075.
• Following the transaction, Radhakrishnan directly owns 77,317 shares of Cargo Therapeutics common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reflects a routine transaction for tax purposes, with no indication of positive or negative implications for the company's performance.

Industry Context

This is a routine Form 4 filing, indicating insider activity related to stock compensation and tax obligations. It's common for executives to sell shares to cover taxes when restricted stock units vest.

Key Dates

Keywords

Cargo Therapeutics, CRGX, Anup Radhakrishnan, stock sale, Form 4, insider trading, tax withholding, restricted stock units